alzposition.blogspot.com
Alzheimer: January 2012
http://alzposition.blogspot.com/2012_01_01_archive.html
Blog, news and companies for neurodegenerative diseases, disorders, alzheimer, screening test, brain, memory, dementia, diagnostic, treatment, vaccine, neurologic, Neuroscience, cognitive deficits,Alzheimer's disease Assessment Scale. Pharmaceuticals Search Engine [selected websites]. Aphios Awarded Phase II SBIR Grant From National . Targacept : Decision by AstraZeneca to Advance AZD. Abbott Biotech Ventures Invests in NeuroGenetic Ph. Thursday, January 26, 2012. Publié par Benjamin de Bélizal. A clinic...
neurogeneticpharmaceuticals.com
NeuroGenetic Pharmaceuticals | Press Releases
http://neurogeneticpharmaceuticals.com/press-releases
Products & Technology. FDA Approves NeuroGenetic Pharmaceuticals Application To Begin Clinical Trials for its NGP 555 Compound to Treat and Prevent Alzheimer’s Disease. NGP 555 prevented the formation of and the deposition of amyloid plaques, thereby precluding neuronal cell death and the dementia associated with AD, said Comer. Comer said NGP anticipates it will begin Phase I human clinical trials by the end of 2014. About NeuroGenetic Pharmaceuticals, Inc. NeuroGenetic Pharmaceuticals, Inc. (NGP), ...